Monoclonal Immunoglobulin Deposition Disease

Monoclonal Immunoglobulin Deposition Disease — Trials · CancerIndex

Clinical trials

Registered studies

148 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05145816	Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis	recruiting	Phase 1 / Phase 2	37	University of Texas Southwestern Medical CenterOTHER	1	Aug 19, 2026	clinicaltrials
NCT06569147	Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis	recruiting	Phase 1 / Phase 2	49	Dana-Farber Cancer InstituteOTHER	1	Aug 19, 2026	clinicaltrials